Copyright Reports & Markets. All rights reserved.

Global Liquid Tumor Biopsy Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Liquid Tumor Biopsy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 ctDNA
    • 1.2.3 CTC
  • 1.3 Market by Application
    • 1.3.1 Global Liquid Tumor Biopsy Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Clinical Laboratories
    • 1.3.3 Hospital
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Liquid Tumor Biopsy Market Perspective (2016-2027)
  • 2.2 Liquid Tumor Biopsy Growth Trends by Regions
    • 2.2.1 Liquid Tumor Biopsy Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Liquid Tumor Biopsy Historic Market Share by Regions (2016-2021)
    • 2.2.3 Liquid Tumor Biopsy Forecasted Market Size by Regions (2022-2027)
  • 2.3 Liquid Tumor Biopsy Industry Dynamic
    • 2.3.1 Liquid Tumor Biopsy Market Trends
    • 2.3.2 Liquid Tumor Biopsy Market Drivers
    • 2.3.3 Liquid Tumor Biopsy Market Challenges
    • 2.3.4 Liquid Tumor Biopsy Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Liquid Tumor Biopsy Players by Revenue
    • 3.1.1 Global Top Liquid Tumor Biopsy Players by Revenue (2016-2021)
    • 3.1.2 Global Liquid Tumor Biopsy Revenue Market Share by Players (2016-2021)
  • 3.2 Global Liquid Tumor Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Liquid Tumor Biopsy Revenue
  • 3.4 Global Liquid Tumor Biopsy Market Concentration Ratio
    • 3.4.1 Global Liquid Tumor Biopsy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Liquid Tumor Biopsy Revenue in 2020
  • 3.5 Liquid Tumor Biopsy Key Players Head office and Area Served
  • 3.6 Key Players Liquid Tumor Biopsy Product Solution and Service
  • 3.7 Date of Enter into Liquid Tumor Biopsy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Liquid Tumor Biopsy Breakdown Data by Type

  • 4.1 Global Liquid Tumor Biopsy Historic Market Size by Type (2016-2021)
  • 4.2 Global Liquid Tumor Biopsy Forecasted Market Size by Type (2022-2027)

5 Liquid Tumor Biopsy Breakdown Data by Application

  • 5.1 Global Liquid Tumor Biopsy Historic Market Size by Application (2016-2021)
  • 5.2 Global Liquid Tumor Biopsy Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Liquid Tumor Biopsy Market Size (2016-2027)
  • 6.2 North America Liquid Tumor Biopsy Market Size by Type
    • 6.2.1 North America Liquid Tumor Biopsy Market Size by Type (2016-2021)
    • 6.2.2 North America Liquid Tumor Biopsy Market Size by Type (2022-2027)
    • 6.2.3 North America Liquid Tumor Biopsy Market Size by Type (2016-2027)
  • 6.3 North America Liquid Tumor Biopsy Market Size by Application
    • 6.3.1 North America Liquid Tumor Biopsy Market Size by Application (2016-2021)
    • 6.3.2 North America Liquid Tumor Biopsy Market Size by Application (2022-2027)
    • 6.3.3 North America Liquid Tumor Biopsy Market Size by Application (2016-2027)
  • 6.4 North America Liquid Tumor Biopsy Market Size by Country
    • 6.4.1 North America Liquid Tumor Biopsy Market Size by Country (2016-2021)
    • 6.4.2 North America Liquid Tumor Biopsy Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Liquid Tumor Biopsy Market Size (2016-2027)
  • 7.2 Europe Liquid Tumor Biopsy Market Size by Type
    • 7.2.1 Europe Liquid Tumor Biopsy Market Size by Type (2016-2021)
    • 7.2.2 Europe Liquid Tumor Biopsy Market Size by Type (2022-2027)
    • 7.2.3 Europe Liquid Tumor Biopsy Market Size by Type (2016-2027)
  • 7.3 Europe Liquid Tumor Biopsy Market Size by Application
    • 7.3.1 Europe Liquid Tumor Biopsy Market Size by Application (2016-2021)
    • 7.3.2 Europe Liquid Tumor Biopsy Market Size by Application (2022-2027)
    • 7.3.3 Europe Liquid Tumor Biopsy Market Size by Application (2016-2027)
  • 7.4 Europe Liquid Tumor Biopsy Market Size by Country
    • 7.4.1 Europe Liquid Tumor Biopsy Market Size by Country (2016-2021)
    • 7.4.2 Europe Liquid Tumor Biopsy Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Liquid Tumor Biopsy Market Size (2016-2027)
  • 8.2 Asia-Pacific Liquid Tumor Biopsy Market Size by Type
    • 8.2.1 Asia-Pacific Liquid Tumor Biopsy Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Liquid Tumor Biopsy Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Liquid Tumor Biopsy Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Liquid Tumor Biopsy Market Size by Application
    • 8.3.1 Asia-Pacific Liquid Tumor Biopsy Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Liquid Tumor Biopsy Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Liquid Tumor Biopsy Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Liquid Tumor Biopsy Market Size by Region
    • 8.4.1 Asia-Pacific Liquid Tumor Biopsy Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Liquid Tumor Biopsy Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Liquid Tumor Biopsy Market Size (2016-2027)
  • 9.2 Latin America Liquid Tumor Biopsy Market Size by Type
    • 9.2.1 Latin America Liquid Tumor Biopsy Market Size by Type (2016-2021)
    • 9.2.2 Latin America Liquid Tumor Biopsy Market Size by Type (2022-2027)
    • 9.2.3 Latin America Liquid Tumor Biopsy Market Size by Type (2016-2027)
  • 9.3 Latin America Liquid Tumor Biopsy Market Size by Application
    • 9.3.1 Latin America Liquid Tumor Biopsy Market Size by Application (2016-2021)
    • 9.3.2 Latin America Liquid Tumor Biopsy Market Size by Application (2022-2027)
    • 9.3.3 Latin America Liquid Tumor Biopsy Market Size by Application (2016-2027)
  • 9.4 Latin America Liquid Tumor Biopsy Market Size by Country
    • 9.4.1 Latin America Liquid Tumor Biopsy Market Size by Country (2016-2021)
    • 9.4.2 Latin America Liquid Tumor Biopsy Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Liquid Tumor Biopsy Market Size (2016-2027)
  • 10.2 Middle East & Africa Liquid Tumor Biopsy Market Size by Type
    • 10.2.1 Middle East & Africa Liquid Tumor Biopsy Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Liquid Tumor Biopsy Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Liquid Tumor Biopsy Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Liquid Tumor Biopsy Market Size by Application
    • 10.3.1 Middle East & Africa Liquid Tumor Biopsy Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Liquid Tumor Biopsy Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Liquid Tumor Biopsy Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Liquid Tumor Biopsy Market Size by Country
    • 10.4.1 Middle East & Africa Liquid Tumor Biopsy Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Liquid Tumor Biopsy Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview
    • 11.1.3 Abbott Laboratories Liquid Tumor Biopsy Introduction
    • 11.1.4 Abbott Laboratories Revenue in Liquid Tumor Biopsy Business (2016-2021)
    • 11.1.5 Abbott Laboratories Recent Development
  • 11.2 Bio-Rad Laboratories
    • 11.2.1 Bio-Rad Laboratories Company Details
    • 11.2.2 Bio-Rad Laboratories Business Overview
    • 11.2.3 Bio-Rad Laboratories Liquid Tumor Biopsy Introduction
    • 11.2.4 Bio-Rad Laboratories Revenue in Liquid Tumor Biopsy Business (2016-2021)
    • 11.2.5 Bio-Rad Laboratories Recent Development
  • 11.3 F. Hoffmann-La Roche
    • 11.3.1 F. Hoffmann-La Roche Company Details
    • 11.3.2 F. Hoffmann-La Roche Business Overview
    • 11.3.3 F. Hoffmann-La Roche Liquid Tumor Biopsy Introduction
    • 11.3.4 F. Hoffmann-La Roche Revenue in Liquid Tumor Biopsy Business (2016-2021)
    • 11.3.5 F. Hoffmann-La Roche Recent Development
  • 11.4 Illumina
    • 11.4.1 Illumina Company Details
    • 11.4.2 Illumina Business Overview
    • 11.4.3 Illumina Liquid Tumor Biopsy Introduction
    • 11.4.4 Illumina Revenue in Liquid Tumor Biopsy Business (2016-2021)
    • 11.4.5 Illumina Recent Development
  • 11.5 QIAGEN N.V.
    • 11.5.1 QIAGEN N.V. Company Details
    • 11.5.2 QIAGEN N.V. Business Overview
    • 11.5.3 QIAGEN N.V. Liquid Tumor Biopsy Introduction
    • 11.5.4 QIAGEN N.V. Revenue in Liquid Tumor Biopsy Business (2016-2021)
    • 11.5.5 QIAGEN N.V. Recent Development
  • 11.6 Thermo Fisher Scientific
    • 11.6.1 Thermo Fisher Scientific Company Details
    • 11.6.2 Thermo Fisher Scientific Business Overview
    • 11.6.3 Thermo Fisher Scientific Liquid Tumor Biopsy Introduction
    • 11.6.4 Thermo Fisher Scientific Revenue in Liquid Tumor Biopsy Business (2016-2021)
    • 11.6.5 Thermo Fisher Scientific Recent Development
  • 11.7 Amoy Diagnostics
    • 11.7.1 Amoy Diagnostics Company Details
    • 11.7.2 Amoy Diagnostics Business Overview
    • 11.7.3 Amoy Diagnostics Liquid Tumor Biopsy Introduction
    • 11.7.4 Amoy Diagnostics Revenue in Liquid Tumor Biopsy Business (2016-2021)
    • 11.7.5 Amoy Diagnostics Recent Development
  • 11.8 HaploX
    • 11.8.1 HaploX Company Details
    • 11.8.2 HaploX Business Overview
    • 11.8.3 HaploX Liquid Tumor Biopsy Introduction
    • 11.8.4 HaploX Revenue in Liquid Tumor Biopsy Business (2016-2021)
    • 11.8.5 HaploX Recent Development
  • 11.9 Whole Genome Sequencing
    • 11.9.1 Whole Genome Sequencing Company Details
    • 11.9.2 Whole Genome Sequencing Business Overview
    • 11.9.3 Whole Genome Sequencing Liquid Tumor Biopsy Introduction
    • 11.9.4 Whole Genome Sequencing Revenue in Liquid Tumor Biopsy Business (2016-2021)
    • 11.9.5 Whole Genome Sequencing Recent Development
  • 11.10 Burning Rock Biotech
    • 11.10.1 Burning Rock Biotech Company Details
    • 11.10.2 Burning Rock Biotech Business Overview
    • 11.10.3 Burning Rock Biotech Liquid Tumor Biopsy Introduction
    • 11.10.4 Burning Rock Biotech Revenue in Liquid Tumor Biopsy Business (2016-2021)
    • 11.10.5 Burning Rock Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Liquid Tumor Biopsy Scope and Market Size
    Liquid Tumor Biopsy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Liquid Tumor Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    ctDNA
    CTC

    Segment by Application
    Clinical Laboratories
    Hospital

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Abbott Laboratories
    Bio-Rad Laboratories
    F. Hoffmann-La Roche
    Illumina
    QIAGEN N.V.
    Thermo Fisher Scientific
    Amoy Diagnostics
    HaploX
    Whole Genome Sequencing
    Burning Rock Biotech

    Buy now